A Long Term Analysis of The Clinical And Cost Effectiveness of Glatiramer Acetate From The Uk Multiple Sclerosis Risk Sharing Scheme. Sumra M, Walters E Value Health. 2015 Nov; 18(7):A765-6. Epub 2015 Oct 20. PMID: 26534287. Abstract CommentRecommendBookmarkWatch